AbstractObjectives
Ukgan-san does not appear in Traditional Korean Medicine classics. However, it has been used in research and clinical applications in Korea. In this paper, we are aiming to examine the records concerned with Ukgan-san to the present, and announce the present usage state in Korea.
MethodsWe searched and summarized the contents of previous medical books about Ukgan-san. In order to investigate the current status of utilization of Ukgan-san in Korea, a bibliographic database of Korea, a database of clinical researches, and a database of pharmaceuticals of the Korea Food and Drug Administration were searched.
ResultsAs a result of searching Ukgan-san related documents, Ukgan-san has been developed in China (Ming dynasty). However, its clinical application has been expanded by modern Japanese kampo medicine doctors. In Korea, cases of Parkinson’s disease, other movement disorders, and psychiatric disorders have been reported, and randomized controlled trials had been done and planned. In addition, some extracts which are consisted of Ukgan-san are also available.
참고문헌1. Chinese Text Project. Boyeongchwalyo. 保嬰撮要. 2016. Available at: URL:https://ctext.org/wiki.pl?if=gb&res=664599
Accessed August 15, 2018.
![]() ![]() 2. Kinebuchi A, Kosoto H, Kimura Y, Fujii Y, Inaki K, Nagao S, et al. Yokukansan Desecriptions in the Original Texts. Kampo Med. 2014; 65:3. 180–4.
![]() 3. Chinese Text Project. Seolsiuian. 薛氏醫案. 2016. Available at: URL:https://ctext.org/wiki.pl?if=gb&res=942002
Accessed August 15, 2018.
![]() ![]() 6. Chinese Text Project. Jeungchijunseung. 證治準繩. 2016. Available at: URL:https://ctext.org/wiki.pl?if=gb&res=227348
Accessed August 15, 2018.
![]() ![]() 7. Korea Institute of Oriental Medicine. Korean traditional medicine classical DB Gyeongakjeonseo. 景岳全書. 62:2018. Availabe at: URL:https://mediclassics.kr/books/139/volume/62
Accessed August 15, 2018.
14. Japanese Society of Neurology. Clinical Practice Guidelines of Dementia 2017. 認知症疾患診療ガイドライン2017. 2017. Availabe at: URL:https://www.neurology-jp.org/guidelinem/nintisyo_2017.html (Japanese)Accessed August 15, 2018.
![]() 15. Japanese Society of Geriatric Medicine. Safety Drug Therapy Guidelines for the Elderly 2015. 高齢者の安全な薬物療法ガイドライン2015. Tokyo: Medical Review Co. Ltd.;2015. p. 141(Japanese).
16. Japanese Society of Neurology. Parkinson’s disease treatment guidelines 2011. パーキンソン病治療ガイドライン2011. Tokyo: Igakushoin;2011. p. 165(Japanese).
17. Kim KN, Cho SH. Review of Clinical Trials about Herbal Medicine for Vascular Dementia. J of Oriental Neuropsychiatry. 2012; 23:4. 37–48.
![]() 18. Lee YE, Lee DH, Lee JH, Lu HY, Cho SY, Park JM, et al. Three Case Reports of Postural Instability and Gait Difficulty in Parkinson’s Disease Patients Treated with Korean and Western Medicine. Korean Jounral of Acupuncture. 2014; 31:1. 40–47.
![]() 19. Yang SB, Kim YJ, Lee HM, Lee HJ, Cho SY, Park JM, et al. Effects of Korean Medicine on Patients with Idiopathic Parkinson’s Disease: A Retrospective Study. J Int Korean Med. 2016; 37:4. 653–660.
![]() 20. Kim YJ, Yang SB, Kim JH, Lee BY, Cho SY, Park SU, et al. Case of Drug-Induced Parkinsonism Treated with Traditional Korean Medicine. J Int Korean Med. 2016; 3:2. 381–388.
21. Park MJ, Lee MR, Kim GM, Cho KH, Moon SK, Kwon S, et al. A Case Report of a Patient with Lewy’s Body Dementia and Insomnia Treated with Korean Medicine. J Int Korean Med. 2017; 38:2. 146–151.
![]() 22. Kim SY, Park JH, Ahn JH, Jo JJ, Lee SM, Kang JW, et al. A Case Report of a Right-sided Hemichorea Patient Diagnosed with Chorea Hyperglycemia Basal Ganglia Syndrome: A Combined Western-Korean Medicine Approach. The Acupuncture. 2016; 33:1. 117–125.
![]() 23. Park MC, Hong SU. Two cases of the treatment of hemifacial spasm improved by Ukgansangami-bang(抑肝散加味方) and moxa-treatment. J Korean Orient Med Ophtal & Oto & Derm. 2007; 20: 3. 236–242.
24. Lee MR, Kim SB, Woo JM, Kang AR, Cho KH, Moon SK, et al. Case Study of a Patient with Dystonia Due to Dystonic Cerebral Palsy Treated with Traditional Korean Medicine. J Int Korean Med. 2016; 37:2. 257–264.
25. Park SM, Kang BG, Lee JW, Na RH, Bang CH, Gang SO, et al. Clinical Case Report of Restless Leg Syndrome in Ischemic Stroke Patients. Korean J Oriental Physiol & Pathol. 2008; 22:4. 975–981.
26. Kim JH, Oh YL, Lee JH, Kim TH, Lyu YS, Kang HW. A Case Report of Typical Oriental Medical Therapy in Combination with Neurofeedback on ADHD Chil. J of Oriental Neuropsychiatry. 2006; 17:3. 157–164.
27. Seo JH, Kang HS, Kim JY, Sung WY, Na YJ, Kim JW. A Case Report of a Patient with Weakness of Heart and Gall bladder type Somatization disorder induced by Stress. J of Oriental Neuropsychiatry. 2007; 18:3. 249–260.
28. Jung H, Sung WY, Lee S, Son JH, Hang SH. A clinical report of a patient with Tourett’s disorder. J of Oriental Neuropsychiatry. 2003; 14:2. 213–218.
29. Hyun WC, Lee SR. Studies on the Effect of AntiConvulsion and Analgesic by Ukgansan and Ukgansangami. J of Oreintal Neuropsychiatry. 1994; 5:1. 69–79.
30. Kim KS, Sung GK, Moon BS. An Experimental Study on the Antiepileptic Effects of Ukgansan
. KIMS. 1998; 19:1. 57–72.
31. Cho MY, Shin YJ, Ha YJ, Woo C, Kim TJ, You JY, et al. Protective Effects of Ukgan-san in CoCl2-induced Cell Death of C6 Glial Cells. Korean J Orient Int Med. 2013; 34:2. 178–191.
32. Kim SM. Effects of Ukgan-san on the L-thyroxine-indcued Rat Hyperthyroidism. Korean J Oriental Physiology & Pathology. 2012; 26:5. 679–686.
33. Shim YH, Park JY, Choi WW, Min IK, Park SU, Jung WS, et al. Herbal medicine treatment for drug-induced parkinsonism. J Altern Complement Med. 2015; May. 21:5. 273–80.
![]() ![]() 34. KCDC and National Research Institute of Health. CRIS(Clinical Research Information Service). 2018. Availabe from: URL:https://cris.nih.go.kr/cris/index.jsp
Accessed August 15, 2018.
35. Korea Food & Drug Administration. KFDA Online Medicine Library. 2018. Availabe at: URL: http://drug.mfds.go.kr/html
Accessed August 15, 2018.
|
|